Covaxin is a national medical achievement of India. During the pandemic and after a long lockdown and a second wave, not only India but the whole world needed the vaccine to control the situation. India completed this need by developing Covaxin. The vaccine developed by Bharat Biotech has already been given approval for emergency use in India. The vaccine received a lot of criticism because of its delay in publishing clinic trial results. Covaxin proved its worth with time, the vaccine is currently being used to inoculated Indian’s along with Covishield and Sputnik V. Covaxin is all ready to get authorization from WHO. The data has been submitted by the vaccine developers to WHO and WHO has started the reviewing process. The authorization is to be granted by 6 October 2021. After being WHO approved the vaccine will be used for the vaccination process worldwide. The Indian that has completed their vaccination from Covaxin would not have to go through the vaccination procedure again in any other country. This authorization is very important for Bharat Biotech’s Covaxin. The approval will not only help in increasing the vaccination process but would be a milestone achievement for India as well.